The Global Sacral Nerve Stimulation Market size is expected to reach $595.9 million by 2030, rising at a market growth of 5.1% CAGR during the forecast period.
The North America region is growing because of the rising treatment awareness, the incidence of OAB and urge incontinence, and the presence of reputable medical institutions. Therefore, North America region acquired $158.2 million revenue in the market in 2022. Furthermore, the market in this area is anticipated to be driven by the rapid use of technologically advanced medical products, like implantable SNS devices. The development of the local sacral nerve stimulation market is also positively impacted by rising reimbursements for technological advancements in equipment and therapeutic methods. Some of the factors impacting the market are Rising elderly population globally, rising prevalence of urological disorders, and the cost of SNS devices and procedures is generally high.
Incontinence is more common at night for most people with overactive bladder (OAB), a combination of symptoms that produce frequent and urgent urination urges. In persons 65 and older, an overactive bladder is common. OAB can develop in females at an earlier age, typically around 45. Incontinence is not only endangered by disorders or trauma. Similar to how the number of people 80 years or older is projected to treble between 2020 and 2050 to approach 426 million. As a result, the data above suggests that the aging global population would drive market growth throughout the projection period. Urological conditions are becoming more commonplace worldwide. Almost all ages can be affected by urologic illnesses and ailments, which also result in high healthcare expenses and can lead to disability, lower quality of life, and other complications. The requirement for sacral neuromodulation therapy is heightened by bladder dysfunction brought on by underlying neurological conditions such as cerebral palsy and stroke, as well as spinal trauma. As a result, it is projected that the increasing prevalence of urological illnesses will aid in market growth globally.
However, the expense of sacral nerve stimulation (SNS) devices and treatments is a substantial barrier to the market for SNS. For some individuals and healthcare systems, the costs associated with implanting & maintaining SNS devices may make them less likely to use them. The price of the treatment will increase as a result. Particularly in areas with scarce healthcare resources or financial constraints, the high cost of SNS devices and associated expenses may prevent widespread adoption and restrict market expansion.
Application Outlook
Based on application, the market is classified into urinary & fecal incontinence, chronic anal fissure, and others. In 2022, the urinary & fecal incontinence segment witnessed the largest revenue share in the market. This is because disorders including fecal impaction, interstitial cystitis, voiding dysfunction, and obstetric trauma are becoming more common. Urinary & fecal incontinence is caused by several diseases that impair bladder and bowel control. Consequently, these disorders call for a focused approach to dealing with the underlying nerve dysfunction related to them. The segment's expansion is also fueled by the market's major players' increased interest in developing stimulators with broad use.
Product Outlook
By product, the market is segmented into devices and accessories. The accessories segment acquired a substantial revenue share in the market in 2022. The need for associated accessories is rising with the widespread acceptance of SNS therapy for ailments such as fecal incontinence, chronic pelvic pain, and urine incontinence. Patients undergoing SNS treatments need certain accessories to support the operation of their implanted devices.
End User Outlook
On the basis of end users, the market is categorized into hospitals, specialty clinics, and others. In 2022, the hospital segment dominated the market by generating the largest revenue share. This is due to the widespread use of sacral nerve stimulation therapy made possible by the accessibility and availability of qualified healthcare professionals, cutting-edge medical technologies and infrastructure, and solid working partnerships with insurance companies.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific region garnered a significant revenue share in the market in 2022. This results from the rising number of people with urine and fecal incontinence. Additionally, numerous NGOs' awareness campaigns will help increase demand. The market is also driven by multiple significant corporations in countries with economies like China and Japan.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Axonics, Inc., Beijing PINS Medical Co., Ltd., PZMed, Laborie Medical Technologies, Synapse BioMedical, Inc., Johnson and Johnson, LivaNova PLC, Boston Scientific Corporation, and Saluda Medical Pty Ltd.
Scope of the Study
Market Segments covered in the Report:
By Application
- Urinary & Fecal Incontinence
- Chronic Anal Fissure
- Others
By Product
By End User
- Hospitals
- Specialty Clinics
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Medtronic PLC
- Axonics, Inc.
- Beijing PINS Medical Co., Ltd.
- PZMed
- Laborie Medical Technologies
- Synapse BioMedical, Inc.
- Johnson and Johnson
- LivaNova PLC
- Boston Scientific Corporation
- Saluda Medical Pty Ltd.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Global Sacral Nerve Stimulation Market, by Application
- 1.4.2 Global Sacral Nerve Stimulation Market, by Product
- 1.4.3 Global Sacral Nerve Stimulation Market, by End User
- 1.4.4 Global Sacral Nerve Stimulation Market, by Geography
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter's Five Force Analysis
Chapter 4. Global Sacral Nerve Stimulation Market by Application
- 4.1 Global Urinary & Fecal Incontinence Market by Region
- 4.2 Global Chronic Anal Fissure Market by Region
- 4.3 Global Others Market by Region
Chapter 5. Global Sacral Nerve Stimulation Market by Product
- 5.1 Global Devices Market by Region
- 5.2 Global Accessories Market by Region
Chapter 6. Global Sacral Nerve Stimulation Market by End User
- 6.1 Global Hospitals Market by Region
- 6.2 Global Specialty Clinics Market by Region
- 6.3 Global Others Market by Region
Chapter 7. Global Sacral Nerve Stimulation Market by Region
- 7.1 North America Sacral Nerve Stimulation Market
- 7.1.1 North America Sacral Nerve Stimulation Market by Application
- 7.1.1.1 North America Urinary & Fecal Incontinence Market by Country
- 7.1.1.2 North America Chronic Anal Fissure Market by Country
- 7.1.1.3 North America Others Market by Country
- 7.1.2 North America Sacral Nerve Stimulation Market by Product
- 7.1.2.1 North America Devices Market by Country
- 7.1.2.2 North America Accessories Market by Country
- 7.1.3 North America Sacral Nerve Stimulation Market by End User
- 7.1.3.1 North America Hospitals Market by Country
- 7.1.3.2 North America Specialty Clinics Market by Country
- 7.1.3.3 North America Others Market by Country
- 7.1.4 North America Sacral Nerve Stimulation Market by Country
- 7.1.4.1 US Sacral Nerve Stimulation Market
- 7.1.4.1.1 US Sacral Nerve Stimulation Market by Application
- 7.1.4.1.2 US Sacral Nerve Stimulation Market by Product
- 7.1.4.1.3 US Sacral Nerve Stimulation Market by End User
- 7.1.4.2 Canada Sacral Nerve Stimulation Market
- 7.1.4.2.1 Canada Sacral Nerve Stimulation Market by Application
- 7.1.4.2.2 Canada Sacral Nerve Stimulation Market by Product
- 7.1.4.2.3 Canada Sacral Nerve Stimulation Market by End User
- 7.1.4.3 Mexico Sacral Nerve Stimulation Market
- 7.1.4.3.1 Mexico Sacral Nerve Stimulation Market by Application
- 7.1.4.3.2 Mexico Sacral Nerve Stimulation Market by Product
- 7.1.4.3.3 Mexico Sacral Nerve Stimulation Market by End User
- 7.1.4.4 Rest of North America Sacral Nerve Stimulation Market
- 7.1.4.4.1 Rest of North America Sacral Nerve Stimulation Market by Application
- 7.1.4.4.2 Rest of North America Sacral Nerve Stimulation Market by Product
- 7.1.4.4.3 Rest of North America Sacral Nerve Stimulation Market by End User
- 7.2 Europe Sacral Nerve Stimulation Market
- 7.2.1 Europe Sacral Nerve Stimulation Market by Application
- 7.2.1.1 Europe Urinary & Fecal Incontinence Market by Country
- 7.2.1.2 Europe Chronic Anal Fissure Market by Country
- 7.2.1.3 Europe Others Market by Country
- 7.2.2 Europe Sacral Nerve Stimulation Market by Product
- 7.2.2.1 Europe Devices Market by Country
- 7.2.2.2 Europe Accessories Market by Country
- 7.2.3 Europe Sacral Nerve Stimulation Market by End User
- 7.2.3.1 Europe Hospitals Market by Country
- 7.2.3.2 Europe Specialty Clinics Market by Country
- 7.2.3.3 Europe Others Market by Country
- 7.2.4 Europe Sacral Nerve Stimulation Market by Country
- 7.2.4.1 Germany Sacral Nerve Stimulation Market
- 7.2.4.1.1 Germany Sacral Nerve Stimulation Market by Application
- 7.2.4.1.2 Germany Sacral Nerve Stimulation Market by Product
- 7.2.4.1.3 Germany Sacral Nerve Stimulation Market by End User
- 7.2.4.2 UK Sacral Nerve Stimulation Market
- 7.2.4.2.1 UK Sacral Nerve Stimulation Market by Application
- 7.2.4.2.2 UK Sacral Nerve Stimulation Market by Product
- 7.2.4.2.3 UK Sacral Nerve Stimulation Market by End User
- 7.2.4.3 France Sacral Nerve Stimulation Market
- 7.2.4.3.1 France Sacral Nerve Stimulation Market by Application
- 7.2.4.3.2 France Sacral Nerve Stimulation Market by Product
- 7.2.4.3.3 France Sacral Nerve Stimulation Market by End User
- 7.2.4.4 Russia Sacral Nerve Stimulation Market
- 7.2.4.4.1 Russia Sacral Nerve Stimulation Market by Application
- 7.2.4.4.2 Russia Sacral Nerve Stimulation Market by Product
- 7.2.4.4.3 Russia Sacral Nerve Stimulation Market by End User
- 7.2.4.5 Spain Sacral Nerve Stimulation Market
- 7.2.4.5.1 Spain Sacral Nerve Stimulation Market by Application
- 7.2.4.5.2 Spain Sacral Nerve Stimulation Market by Product
- 7.2.4.5.3 Spain Sacral Nerve Stimulation Market by End User
- 7.2.4.6 Italy Sacral Nerve Stimulation Market
- 7.2.4.6.1 Italy Sacral Nerve Stimulation Market by Application
- 7.2.4.6.2 Italy Sacral Nerve Stimulation Market by Product
- 7.2.4.6.3 Italy Sacral Nerve Stimulation Market by End User
- 7.2.4.7 Rest of Europe Sacral Nerve Stimulation Market
- 7.2.4.7.1 Rest of Europe Sacral Nerve Stimulation Market by Application
- 7.2.4.7.2 Rest of Europe Sacral Nerve Stimulation Market by Product
- 7.2.4.7.3 Rest of Europe Sacral Nerve Stimulation Market by End User
- 7.3 Asia Pacific Sacral Nerve Stimulation Market
- 7.3.1 Asia Pacific Sacral Nerve Stimulation Market by Application
- 7.3.1.1 Asia Pacific Urinary & Fecal Incontinence Market by Country
- 7.3.1.2 Asia Pacific Chronic Anal Fissure Market by Country
- 7.3.1.3 Asia Pacific Others Market by Country
- 7.3.2 Asia Pacific Sacral Nerve Stimulation Market by Product
- 7.3.2.1 Asia Pacific Devices Market by Country
- 7.3.2.2 Asia Pacific Accessories Market by Country
- 7.3.3 Asia Pacific Sacral Nerve Stimulation Market by End User
- 7.3.3.1 Asia Pacific Hospitals Market by Country
- 7.3.3.2 Asia Pacific Specialty Clinics Market by Country
- 7.3.3.3 Asia Pacific Others Market by Country
- 7.3.4 Asia Pacific Sacral Nerve Stimulation Market by Country
- 7.3.4.1 China Sacral Nerve Stimulation Market
- 7.3.4.1.1 China Sacral Nerve Stimulation Market by Application
- 7.3.4.1.2 China Sacral Nerve Stimulation Market by Product
- 7.3.4.1.3 China Sacral Nerve Stimulation Market by End User
- 7.3.4.2 Japan Sacral Nerve Stimulation Market
- 7.3.4.2.1 Japan Sacral Nerve Stimulation Market by Application
- 7.3.4.2.2 Japan Sacral Nerve Stimulation Market by Product
- 7.3.4.2.3 Japan Sacral Nerve Stimulation Market by End User
- 7.3.4.3 India Sacral Nerve Stimulation Market
- 7.3.4.3.1 India Sacral Nerve Stimulation Market by Application
- 7.3.4.3.2 India Sacral Nerve Stimulation Market by Product
- 7.3.4.3.3 India Sacral Nerve Stimulation Market by End User
- 7.3.4.4 South Korea Sacral Nerve Stimulation Market
- 7.3.4.4.1 South Korea Sacral Nerve Stimulation Market by Application
- 7.3.4.4.2 South Korea Sacral Nerve Stimulation Market by Product
- 7.3.4.4.3 South Korea Sacral Nerve Stimulation Market by End User
- 7.3.4.5 Singapore Sacral Nerve Stimulation Market
- 7.3.4.5.1 Singapore Sacral Nerve Stimulation Market by Application
- 7.3.4.5.2 Singapore Sacral Nerve Stimulation Market by Product
- 7.3.4.5.3 Singapore Sacral Nerve Stimulation Market by End User
- 7.3.4.6 Malaysia Sacral Nerve Stimulation Market
- 7.3.4.6.1 Malaysia Sacral Nerve Stimulation Market by Application
- 7.3.4.6.2 Malaysia Sacral Nerve Stimulation Market by Product
- 7.3.4.6.3 Malaysia Sacral Nerve Stimulation Market by End User
- 7.3.4.7 Rest of Asia Pacific Sacral Nerve Stimulation Market
- 7.3.4.7.1 Rest of Asia Pacific Sacral Nerve Stimulation Market by Application
- 7.3.4.7.2 Rest of Asia Pacific Sacral Nerve Stimulation Market by Product
- 7.3.4.7.3 Rest of Asia Pacific Sacral Nerve Stimulation Market by End User
- 7.4 LAMEA Sacral Nerve Stimulation Market
- 7.4.1 LAMEA Sacral Nerve Stimulation Market by Application
- 7.4.1.1 LAMEA Urinary & Fecal Incontinence Market by Country
- 7.4.1.2 LAMEA Chronic Anal Fissure Market by Country
- 7.4.1.3 LAMEA Others Market by Country
- 7.4.2 LAMEA Sacral Nerve Stimulation Market by Product
- 7.4.2.1 LAMEA Devices Market by Country
- 7.4.2.2 LAMEA Accessories Market by Country
- 7.4.3 LAMEA Sacral Nerve Stimulation Market by End User
- 7.4.3.1 LAMEA Hospitals Market by Country
- 7.4.3.2 LAMEA Specialty Clinics Market by Country
- 7.4.3.3 LAMEA Others Market by Country
- 7.4.4 LAMEA Sacral Nerve Stimulation Market by Country
- 7.4.4.1 Brazil Sacral Nerve Stimulation Market
- 7.4.4.1.1 Brazil Sacral Nerve Stimulation Market by Application
- 7.4.4.1.2 Brazil Sacral Nerve Stimulation Market by Product
- 7.4.4.1.3 Brazil Sacral Nerve Stimulation Market by End User
- 7.4.4.2 Argentina Sacral Nerve Stimulation Market
- 7.4.4.2.1 Argentina Sacral Nerve Stimulation Market by Application
- 7.4.4.2.2 Argentina Sacral Nerve Stimulation Market by Product
- 7.4.4.2.3 Argentina Sacral Nerve Stimulation Market by End User
- 7.4.4.3 UAE Sacral Nerve Stimulation Market
- 7.4.4.3.1 UAE Sacral Nerve Stimulation Market by Application
- 7.4.4.3.2 UAE Sacral Nerve Stimulation Market by Product
- 7.4.4.3.3 UAE Sacral Nerve Stimulation Market by End User
- 7.4.4.4 Saudi Arabia Sacral Nerve Stimulation Market
- 7.4.4.4.1 Saudi Arabia Sacral Nerve Stimulation Market by Application
- 7.4.4.4.2 Saudi Arabia Sacral Nerve Stimulation Market by Product
- 7.4.4.4.3 Saudi Arabia Sacral Nerve Stimulation Market by End User
- 7.4.4.5 South Africa Sacral Nerve Stimulation Market
- 7.4.4.5.1 South Africa Sacral Nerve Stimulation Market by Application
- 7.4.4.5.2 South Africa Sacral Nerve Stimulation Market by Product
- 7.4.4.5.3 South Africa Sacral Nerve Stimulation Market by End User
- 7.4.4.6 Nigeria Sacral Nerve Stimulation Market
- 7.4.4.6.1 Nigeria Sacral Nerve Stimulation Market by Application
- 7.4.4.6.2 Nigeria Sacral Nerve Stimulation Market by Product
- 7.4.4.6.3 Nigeria Sacral Nerve Stimulation Market by End User
- 7.4.4.7 Rest of LAMEA Sacral Nerve Stimulation Market
- 7.4.4.7.1 Rest of LAMEA Sacral Nerve Stimulation Market by Application
- 7.4.4.7.2 Rest of LAMEA Sacral Nerve Stimulation Market by Product
- 7.4.4.7.3 Rest of LAMEA Sacral Nerve Stimulation Market by End User
Chapter 8. Company Profiles
- 8.1 Medtronic PLC
- 8.1.1 Company overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expenses
- 8.1.5 Recent strategies and developments:
- 8.1.5.1 Trials and Approvals:
- 8.1.6 SWOT Analysis
- 8.2 Axonics, Inc.
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Product and Regional Analysis
- 8.2.4 Research & Development Expenses
- 8.2.5 Recent strategies and developments:
- 8.2.6 SWOT Analysis
- 8.3 Beijing PINS Medical Co., Ltd.
- 8.3.1 Company Overview
- 8.3.2 SWOT Analysis
- 8.4 Saluda Medical Pty Ltd.
- 8.4.1 Company Overview
- 8.4.2 SWOT Analysis
- 8.5 PZMed
- 8.5.1 Company Overview
- 8.5.2 SWOT Analysis
- 8.6 LivaNova PLC
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental and Regional Analysis
- 8.6.4 Research & Development Expense
- 8.6.5 SWOT Analysis
- 8.7 Boston Scientific Corporation
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expense
- 8.7.5 SWOT Analysis
- 8.8 Johnson & Johnson
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Segmental & Regional Analysis
- 8.8.4 Research & Development Expenses
- 8.8.5 SWOT Analysis
- 8.9 Synapse BioMedical, Inc.
- 8.9.1 Company Overview
- 8.9.2 SWOT Analysis
- 8.1 Laborie Medical Technologies (Patricia Industries) (Investor AB)
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Regional Analysis
- 8.10.4 SWOT Analysis
Chapter 9. Winning Imperative for Sacral Nerve Stimulation Market